טוען...
Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate
Advancement of RNAi-based therapeutics depends on effective delivery to the site of protein synthesis. Although intravenously administered, multi-component delivery vehicles have enabled small interfering RNA (siRNA) delivery and progression into clinical development, advances of single-component, s...
שמור ב:
הוצא לאור ב: | Mol Ther |
---|---|
Main Authors: | , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
American Society of Gene & Cell Therapy
2017
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363199/ https://ncbi.nlm.nih.gov/pubmed/28129130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2016.10.019 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|